Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  American Journal of Kidney Diseases

• Publication date

  1999-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0272-6386(99)70036-3PMID 10561135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathophysiology of progressive nephropathies.

  1998cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

  1997cited by this paper
• Blood Pressure Control, Proteinuria, and the Progression of Renal Disease

  1995cited by this paper
• Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

  1995cited by this paper
• The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

  1994cited by this paper
• Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease.

  1994cited by this paper
• The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

  1994cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

  1993cited by this paper
• Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.

  1992cited by this paper
• Diabetic nephropathy in insulin-dependent patients.

  1992cited by this paper
• The natural history of diabetic nephropathy.

  1990cited by this paper
• Properties of the urn randomization in clinical trials.

  1988cited by this paper
• The changing natural history of nephropathy in type I diabetes.

  1985cited by this paper
• Two-Sample Asymptotically Distribution-Free Tests for Incomplete Multivariate Observations

  1984cited by this paper
• Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.

  1983cited by this paper
• EDUCATIONAL GRAFFITI: BETTER USE OF THE LAVATORY WALL

  1982cited by this paper
• Random-effects models for longitudinal data.

  1982cited by this paper
• The nephrotic syndrome.

  1979cited by this paper
• Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment.

  1976cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• The clinical course of diabetic nephropathy.

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate.

  1973cited by this paper

• Evaluating the Renal Implications of Intensive Versus Standard Blood Pressure Control in Chronic Kidney Disease: A Systematic Review of Randomized Trials

  2025influential citation
• Blood pressure targets for hypertension in people with chronic renal disease.

  2024cites this paper
• Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms Of Trials.

  2023cites this paper
• Urinary interleukin-9 in youth with type 1 diabetes mellitus

  2022cites this paper
• Controversies in Hypertension II: the Optimal Target Blood Pressure.

  2022cites this paper
• Association of Blood Pressure With the Progression of CKD: Findings From KNOW-CKD Study.

  2021cites this paper
• KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.

  2021cites this paper
• Kidney disease in diabetes: from mechanisms to clinical presentation and treatment strategies.

  2021cites this paper
• Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes

  2021cites this paper
• Strategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy

  2021cites this paper
• Association of metabolic syndrome in type 2 diabetes patients with or without nephropathy

  2020cites this paper
• Blood pressure targets in adults with hypertension.

  2020influential citation
• Focal Segmental Glomerulosclerosis, Adult

  2019cites this paper
• Diabetic Kidney Disease

  2019cites this paper
• Chronic kidney disease referrals from general practitioners pre- and post National Institute for Health and Care Excellence guidance 2014.

  2019cites this paper
• Why Do Patients With Well-Controlled Vascular Risk Factors Develop Progressive Chronic Kidney Disease?

  2019cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2016

  2018cites this paper
• The Validity of Drug Effects on Proteinuria, Albuminuria, Serum Creatinine, and Estimated GFR as Surrogate End Points for ESKD: A Systematic Review.

  2018cites this paper
• Chronic Kidney Disease in Diabetes Diabetes Canada Clinical Practice Guidelines Expert Committee

  2018cites this paper
• Chronic Kidney Disease in Diabetes.

  2018cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2016

  2018cites this paper
• 33 – Hypertension and Chronic Kidney Disease

  2018cites this paper
• Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease

  2017cites this paper
• The Kidney in Hypertension.

  2017cites this paper
• Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial

  2016cites this paper
• Prehypertension in adolescents with cardiovascular risk: a comparison between type 1 diabetic patients and overweight subjects

  2016cites this paper
• Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes

  2016cites this paper
• Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial.

  2016cites this paper
• A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension.

  2016cites this paper
• The Effect of Intensive vs. Usual Blood Pressure Control on Kidney Function Among Persons With Prior Lacunar Stroke: A Post-Hoc Analysis of the SPS3 Randomized Trial

  2016cites this paper
• Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study.

  2015cites this paper
• Caractérisation du gène de l'enzyme de conversion del'angiotensine-2 dans le rein diabétique et implication dans ledéveloppement de la néphropathie diabétique et de l'hypertension

  2015influential citation
• Maintenance Dialysis throughout the World in Years 1990 and 2010.

  2015cites this paper
• BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.

  2015cites this paper
• Chapter 49 – Slowing Progression of Chronic Kidney Disease

  2015cites this paper
• Spironolactone Add-on for Preventing or Slowing the Progression of Diabetic Nephropathy: A Meta-analysis.

  2015cites this paper
• Epidemiology of hypertension in CKD.

  2015cites this paper
• Nutritional management of diabetic nephropathy

  2014cites this paper
• Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?

  2014cites this paper
• Novel effective drugs for diabetic kidney disease? or not?

  2014cites this paper
• Renal outcomes in patients with type 1 diabetes and macroalbuminuria.

  2014cites this paper
• Clinical challenges in diagnosis and management of diabetic kidney disease.

  2014cites this paper
• Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the American College of Physicians

  2013cites this paper
• Slowing progression of chronic kidney disease

  2013cites this paper
• Chapter 30 – Kidney Disease in Hypertension

  2013cites this paper
• Blood pressure targets for hypertension in people with diabetes mellitus.

  2013cites this paper
• European Society of Hypertension Scientific Newsletter : Update on Hypertension Management 2013 ; 14 : No . 55 BLOOD PRESSURE TARGETS FOR PATIENTS WITH CHRONIC KIDNEY DISEASE

  2013cites this paper
• Blood pressure targets for patients with chronic kidney disease

  2013cites this paper
• History of d iabetic n ephropathy: a p ersonal a ccount

  2013cites this paper
• Perindopril treatment in streptozotocin induced diabetic nephropaty.

  2013cites this paper
• Hypertension in chronic kidney disease

  2013cites this paper
• A Stepped Care Approach to the Management of Chronic Kidney Disease

  2012cites this paper
• The effects of blood pressure control levels on the renoprotection of type 2 diabetic patients without overt proteinuria.

  2012cites this paper
• Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline

  2012cites this paper
• Diálise peritoneal no doente diabético

  2012cites this paper
• Slowing the Progression of Adult Chronic Kidney Disease

  2012cites this paper
• Is the lower blood pressure target for patients with chronic kidney disease supported by evidence?

  2012cites this paper
• History of Diabetic Nephropathy: A Personal Account

  2012cites this paper
• Diabetische Nephropathie – Update 2012

  2012cites this paper
• Consent for Research With Biological Samples: One-Time General Consent Versus a Gift Model

  2012cites this paper
• Cost Effectiveness of Ramipril in Patients with Non-Diabetic Nephropathy and Hypertension

  2012cites this paper
• Cellular and molecular mechanisms of diabetic glomerulopathy.

  2012cites this paper
• Risk factors for progression of renal disease in patient with diabetic nephropathy.

  2012cites this paper
• Quinapril

  2012cites this paper
• The value of personalized approaches to improve pharmacotherapy in renal disease

  2012influential citation
• АЛЬБУМИНУРИЯ: АСПЕКТЫ КЛИНИЧЕСКОГО MANYSIDED ALBUMINURIA: ASPECTS OF CLINICAL VALUE

  2012cites this paper
• Guidelines at a crossroads Listening to the evidence - what trials on blood pressure targets in CKD say about current guidelines

  2011cites this paper
• Role of Hypertension and Metabolic Abnormalities in the Development of Diabetic Nephropathy among Egyptian Patients with Type 2 Diabetes

  2011cites this paper
• The Goal of Blood Pressure Control for Prevention of Early Diabetic Microvascular Complications

  2011cites this paper
• Is Nocturnal Blood Pressure Reduction the Secret to Reducing the Rate of Progression of Hypertensive Chronic Kidney Disease?

  2011influential citation
• Goal-directed antihypertensive therapy: Lower may not always be better

  2011cites this paper
• Adaptation to Nephron Loss and Mechanisms of Progression in Chronic Kidney Disease

  2011cites this paper
• Gda ski Uniwersytet Medyczny

  2011cites this paper
• Blood pressure control in chronic kidney disease: is less really more?

  2010cites this paper
• Epidemiology of hypertension in the elderly with chronic kidney disease.

  2010cites this paper
• Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan

  2010cites this paper
• Medication issues in older individuals with CKD.

  2010cites this paper
• Chapter 3 – Diabetic Kidney Disease: Current Challenges

  2010cites this paper
• Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

  2009cites this paper
• Improvement of awareness, treatment and control of hypertension among chronic kidney disease patients in China from 1999 to 2005

  2009cites this paper
• Blood Pressure Guidelines in Chronic Kidney Disease: A Critical Review

  2009influential citation
• Treatment blood pressure targets for hypertension.

  2009cites this paper
• Early Detection and conservative Management of chronic renal failure

  2009cites this paper
• Evidence-based Practice Guideline for the Treatment of CKD

  2009cites this paper
• Integrating albuminuria and GFR in the assessment of diabetic nephropathy

  2009cites this paper
• Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease.

  2009cites this paper
• Low-Dose Losartan Therapy Reduces Proteinuria in Normotensive Patients with Immunoglobulin A Nephropathy

  2008cites this paper
• Molecular mechanisms of proteinuria in diabetes.

  2008cites this paper
• Chapter 62 – Prevention of Progressive Renal Failure

  2008cites this paper
• Chapter 28 – Therapy for Diabetic Nephropathy

  2008cites this paper
• Treating hypertension in the patient with overt diabetic nephropathy.

  2007cites this paper
• Treating diabetic nephropathy: unfinished success is not failure.

  2007cites this paper
• The CARI Guidelines – Caring for Australasians with Renal Impairment Prevention of Progression of Kidney Disease

  2007cites this paper
• Is Renoprotection by Angiotensin Receptor Blocker Dependent on Blood Pressure?: The Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) Study

  2007cites this paper
• Chapter 29 – Kidney Disease in Hypertension

  2007cites this paper
• Supporting Informed Decisions Thiazide Diuretics as First-Line Treatment for Hypertension : Meta-analysis and Economic Evaluation

  2007cites this paper
• European Society of Hypertension Scientific Newsletter: Update on Hypertension Management

  2007cites this paper
• Amlodipine Added to Quinapril vs Quinapril Alone for the Treatment of Hypertension in Diabetes: The Amlodipine in Diabetes (ANDI) Trial

  2007cites this paper
• Reversing the reno-cardiac perspective

  2007cites this paper
• Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.

  2007cites this paper